Perrigo (PRGO) Non Operating Income (2012 - 2026)
Perrigo (PRGO) reported Non Operating Income of $6.0 million for Q1 2026, up 1400.0% year-over-year from $400000.0 in Q1 2025, and up 561.54% quarter-over-quarter from -$1.3 million in Q4 2025.
Perrigo (PRGO) Non Operating Income (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Non Operating Income data on file, last reported at $6.0 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $6.0 million, up 1400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.5 million (down 600.0% YoY), and the FY2025 annual result was -$13.2 million, down 1566.67% from the prior year.
- Non Operating Income advanced to $6.0 million in Q1 2026 per PRGO's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $9.7 million in Q3 2023 and troughed at -$53.8 million in Q3 2022.
- A 5-year average of -$2.9 million and a median of $400000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2026: Non Operating Income plunged 13550.0% in 2022, then jumped 1400.0% in 2026.
- A 5-year view of Non Operating Income shows it stood at -$4.4 million in 2022, then jumped by 118.18% to $800000.0 in 2023, then sank by 50.0% to $400000.0 in 2024, then tumbled by 425.0% to -$1.3 million in 2025, then surged by 561.54% to $6.0 million in 2026.
- Business Quant data shows PRGO's Non Operating Income at $6.0 million in Q1 2026, -$1.3 million in Q4 2025, and -$9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 6.00 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 27, 2025 | -9.60 Mn |
| Jun 28, 2025 | -2.60 Mn |
| Mar 29, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 28, 2024 | 4.10 Mn |
| Jun 29, 2024 | -3.40 Mn |
| Mar 30, 2024 | -400,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jul 1, 2023 | 9.70 Mn |
| Apr 1, 2023 | -500,000.00 |
| Dec 31, 2022 | -4.40 Mn |
| Oct 1, 2022 | 4.00 Mn |
| Jul 2, 2022 | -53.80 Mn |
| Apr 2, 2022 | 1.10 Mn |
| Dec 31, 2021 | -6.30 Mn |
| Oct 2, 2021 | -18.50 Mn |
| Jul 3, 2021 | 400,000.00 |